Literature DB >> 11083782

Multiple mechanisms of phase variation of PorA in Neisseria meningitidis.

A van der Ende1, C T Hopman, J Dankert.   

Abstract

Previously, we reported that PorA expression in Neisseria meningitidis is modulated by variation in the length of the homopolymeric tract of guanidine residues between the -35 and -10 regions of the promoter or by deletion of porA. To reveal additional mechanisms of variation in PorA expression, the meningococcal isolates from 41 patients and 19 carriers were studied. In addition, at least 3 meningococcal isolates from different body parts of each of 11 patients were analyzed. Sequence analysis of the porA promoter showed that the spacer between the -35 and -10 regions varies in length between 14 and 24 bp. PorA expression was observed in strains with a porA promoter spacer of 16 to 24 bp. All but one strain with a porA promoter spacer of 16 to 20 bp and undetectable PorA expression have a homopolymeric tract of 8 or 6 instead of 7 adenine residues in the porA coding region. The other PorA-negative strain had a single-base-pair deletion in the coding region. The highest level of PorA expression was observed in strains with a promoter spacer of 17 or 18 bp. PorA expression was reduced twofold in strains with a porA promoter spacer of 16 or 19 bp. Strains with a 16-bp promoter spacer with substitutions in the polyguanidine tract displayed increased levels of PorA expression compared to strains with a homopolymeric tract of guanidine residues in the porA promoter. In conclusion, meningococci display multiple mechanisms for varying PorA expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083782      PMCID: PMC97767          DOI: 10.1128/IAI.68.12.6685-6690.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis.

Authors:  Michael P Jennings; Yogitha N Srikhanta; E Richard Moxon; Marco Kramer; Jan T Poolman; Betsy Kuipers; Peter van der Ley
Journal:  Microbiology (Reading)       Date:  1999-11       Impact factor: 2.777

Review 2.  Molecular switches--the ON and OFF of bacterial phase variation.

Authors:  I R Henderson; P Owen; J P Nataro
Journal:  Mol Microbiol       Date:  1999-09       Impact factor: 3.501

Review 3.  Variation and control of protein expression in Neisseria.

Authors:  T F Meyer; C P Gibbs; R Haas
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

Review 4.  Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

Authors:  C E Frasch; W D Zollinger; J T Poolman
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

5.  Analysis of E. coli promoter sequences.

Authors:  C B Harley; R P Reynolds
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

6.  Characteristics of major outer membrane proteins of Haemophilus influenzae.

Authors:  L van Alphen; T Riemens; J Poolman; H C Zanen
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

7.  Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay.

Authors:  K Saukkonen; M Leinonen; H Abdillahi; J T Poolman
Journal:  Vaccine       Date:  1989-08       Impact factor: 3.641

8.  Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.

Authors:  K Saukkonen; H Abdillahi; J T Poolman; M Leinonen
Journal:  Microb Pathog       Date:  1987-10       Impact factor: 3.738

9.  Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly.

Authors:  A B Jonsson; G Nyberg; S Normark
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

10.  Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.

Authors:  B McGuinness; A K Barlow; I N Clarke; J E Farley; A Anilionis; J T Poolman; J E Heckels
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

View more
  33 in total

1.  Comparative investigation of the genomic regions involved in antigenic variation of the TprK antigen among treponemal species, subspecies, and strains.

Authors:  Lorenzo Giacani; Stephanie L Brandt; Maritza Puray-Chavez; Tara Brinck Reid; Charmie Godornes; Barbara J Molini; Martin Benzler; Jörg S Hartig; Sheila A Lukehart; Arturo Centurion-Lara
Journal:  J Bacteriol       Date:  2012-06-01       Impact factor: 3.490

2.  Sterilizing immunity elicited by Neisseria meningitidis carriage shows broader protection than predicted by serum antibody cross-reactivity in CEACAM1-humanized mice.

Authors:  Kay O Johswich; Shannon E McCaw; Lea Strobel; Matthias Frosch; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

3.  Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.

Authors:  O B Harrison; B D Robertson; S N Faust; M A Jepson; R D Goldin; M Levin; R S Heyderman
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 4.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

5.  Persistence, replacement, and rapid clonal expansion of meningococcal carriage isolates in a 2008 university student cohort.

Authors:  Fadil A Bidmos; Keith R Neal; Neil J Oldfield; David P J Turner; Dlawer A A Ala'Aldeen; Christopher D Bayliss
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

6.  Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

Authors:  Jianwei Zhou; Frances Jamieson; Sharon Dolman; Linda Mn Hoang; Prasad Rawte; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

7.  Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

Authors:  Carlos J Orihuela; Jafar Mahdavi; Justin Thornton; Beth Mann; Karl G Wooldridge; Noha Abouseada; Neil J Oldfield; Tim Self; Dlawer A A Ala'Aldeen; Elaine I Tuomanen
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

8.  Role of Neisseria meningitidis PorA and PorB expression in antimicrobial susceptibility.

Authors:  Ian R Peak; Courtney D Jennings; Freda E-C Jen; Michael P Jennings
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

Review 9.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 10.  Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.

Authors:  Elisabeth Kugelberg; Bridget Gollan; Christoph M Tang
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.